Brainsway (BRSYF) Gains from Investment Securities (2025 - 2026)
Brainsway posted quarterly Gains from Investment Securities of $7000.0 for Q1 2026, down 74.07% year-on-year from $27000.0 in Q1 2025, and up 100.32% on a QoQ basis from -$2.2 million in Q4 2025.
Brainsway (BRSYF) has 2 years of Gains from Investment Securities data on file, last reported at $7000.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities fell 74.07% year-over-year to $7000.0; the trailing twelve-month figure through Dec 2025 stood at -$2.2 million (changed N/A YoY), and the FY2025 full-year result was -$2.2 million, changed N/A from the prior year.
- Gains from Investment Securities for Q1 2026 stood at $7000.0, up from -$2.2 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $27000.0 in Q1 2025 and bottomed at -$2.2 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Brainsway | - | - | 11.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,000.00 |
| Mar 31, 2026 | 7,000.00 |
| Dec 31, 2025 | -2.19 Mn |
| Dec 31, 2025 | -2.19 Mn |
| Mar 31, 2025 | 27,000.00 |
| Mar 31, 2025 | 27,000.00 |